
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
' The Department of Health and Human Services has announced an expedited drug-review process for fixed-dose combination pills containing one or more anti-HIV medications already approved by the agency and for generic drugs, including combination pills, designed for use in developing nations. ' The Food and Drug Administration gave traditional approval status in April to GlaxoSmithKline nucleoside reverse transcriptase inhibitor Ziagen. The FDA initially approved the drug in December 1998 under the agency's accelerated approval regulations. ' The FDA is expected to announce before the end of the year the approval of GlaxoSmithKline's single pill combining the company's Epivir and Ziagen antiretrovirals, each of which have been separately approved by the agency. The combination pill will be taken once daily. ' The FDA gave priority review status in May to Gilead Sciences' single pill combining the company's Viread and Emtriva antiretroviral medications, each of which have been separately approved by the FDA. A decision by the agency is expected by September 12. ' Pfizer has announced the availability of its protease inhibitor Viracept in a 625-milligram pill, enabling users of the medication to take two pills twice a day'instead of five pills twice a day with the older 250-milligram formulation. ' Drugmakers Bristol-Myers Squibb, Gilead Sciences, and Merck have announced the joint development of a once-daily pill combining a full day's doses of three anti-HIV drugs'Viread, Emtriva, and Sustiva. There was no report as to when the pill would be ready for human testing. ''Roche and Trimeris have announced that their fusion inhibitor, Fuzeon, previously available only through a progressive distribution program, has been made available by prescription at all U.S. pharmacies. ' Gilead Sciences has announced an expansion and simplification of its patient assistance program. The program now provides access to antiretroviral drugs on the same day a prescription is received for the company's drugs, including anti-HIV medications Viread and Emtriva and the hepatitis B treatment Hepsera. ''Boehringer Ingelheim has announced the expansion of its U.S. Open Label Safety Study of its experimental nonpeptidic protease inhibitor, tipranavir, to provide the drug to 50 more patients a month. The expansion broadens the study entry criteria and also doubles the number of OLSS sites nationwide from 33 to 66. ' A study presented at the 10th Anniversary Conference of the British HIV Association shows that trough levels of the protease inhibitor Kaletra, marketed by Abbott Laboratories, are significantly higher in men with low body weight. There were too few women studied to link body weight with blood-based levels of Kaletra in women. ' A panel of HIV experts has released international guidelines for treating HIV-positive adults with the fusion inhibitor Fuzeon.The panel recommends that Fuzeon be given to patients with CD4-cell counts of at least 100 cells and those still responsive to at least two other anti-HIV medications whenever possible. ' Switching from other protease inhibitors to Reyataz, marketed by Bristol-Myers Squibb, can result in rapid improvements in lipodystrophy-associated body shape changes and high blood-lipid levels, according to a study in the April 9 edition of the journal AIDS. ' A study in the April 30 edition of the journal AIDS shows that fat loss from the limbs linked with the use of antiretroviral drugs can be reversed in the long term by switching from Retrovir or Zerit to Ziagen. ' Doctors in South Africa report in the April 30 issue of the journal AIDS the first case of Kaletra failure in a protease-inhibitor'naive individual linked to cross-resistance to other protease drugs. ' A study by researchers in Paris shows that severe cases of kidney toxicity related to use of Gilead Sciences' Viread are rare and reversible once the medication is stopped. The study also shows that risk factors for Viread-related renal problems include taking the drug with the protease inhibitor Norvir and having preexisting kidney deficiencies. ' Treating hepatitis C with pegylated interferon and ribavirin during the first six months of infection can lead to a high rate of viral clearance in adults coinfected with HIV, according to a study presented at the 10th Anniversary Conference of the British HIV Association. ' A study in the May 19 edition of the journal Annals of Internal Medicine shows that GlaxoSmithKline diabetes drug Avandia can improve insulin sensitivity and lessen lipodystrophy symptoms in people taking antiretroviral drugs. ' Researchers report in the May 5 online edition of the journal BMC Medicine that prednisolone can slow the loss of CD4 cells in HIV-positive people. Prednisolone, a corticosteroid, boosted CD4 counts by more than 200 cells during the first two weeks of treatment and on average kept cell counts elevated for at least two years.
From our Sponsors
Most Popular
Lexi Love comes out as HIV+ after Trump deletes federal resources
January 23 2025 11:23 AM
Ricky Martin delivers showstopping performance for 2024 World AIDS Day
December 05 2024 12:08 PM
Trump's orders prompt CDC to erase HIV resources
January 31 2025 5:29 PM
California confirms first case of even more deadly mpox strain
November 18 2024 3:02 PM
This long-term HIV survivor says testosterone therapy helped save his life.
December 16 2024 8:00 PM
Plus: Featured Video
Latest Stories
500,000 Children at Risk: PEPFAR Funding Crisis
April 08 2025 3:51 PM
Broadway's best raise over $1 million for LGBTQ+ and HIV causes
April 03 2025 7:15 PM
The Talk Season 5 premieres this spring with HIV guidance for the newly diagnosed
March 26 2025 1:00 PM
Discover the power of Wellness in your life
March 26 2025 12:41 PM
Season 4 of The Switch on resilience & radical self-love returns this spring
March 26 2025 12:20 PM
Jess King is here to help you live your happiest, healthiest life yet
March 24 2025 4:35 PM
BREAKING NEWS: Trump admin moves to end federal HIV prevention programs
March 18 2025 6:10 PM
Gerald Garth is keeping people of color happy and healthy through trying times
March 11 2025 3:38 PM
Celebrating Black History Month with our annual African American issue
February 01 2025 3:28 PM
Tyler TerMeer vows to continue to fight for health care for all
January 28 2025 3:00 PM
Plus nominated for 2025 GLAAD Media Award
January 22 2025 12:42 PM
A camp for HIV-positive kids is for sale. Here's why its founder is celebrating
January 02 2025 12:21 PM
'RuPaul's Drag Race' star Trinity K Bonet quietly comes out trans
December 15 2024 6:27 PM
AIDS Memorial Quilt displayed at White House for the first time
December 02 2024 1:21 PM
Decades of progress, uniting to fight HIV/AIDS
December 01 2024 12:30 PM
Hollywood must do better on HIV representation
December 01 2024 9:00 AM
Climate change is disrupting access to HIV treatment
November 25 2024 11:05 AM
Post-election blues? Some advice from mental health experts
November 08 2024 12:36 PM
Check out our 2024 year-end issue!
October 28 2024 2:08 PM
Meet our Health Hero of the Year, Armonté Butler
October 21 2024 12:53 PM